Results

Total Results: 1,430 records

Showing results for "continued".

  1. effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Annual Incidence of Foot Ulcer Among Diabetic Medicare Parts A and B Fee-for-Service (FFS) Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of Peripheral Artery Disease (PAD) Algorithm 3: 12-month period of continuous enrollment and continuous FFS enrollment throughout the year. Age…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_executive.pdf
    November 01, 2012 - Summary of evidence on comparative benefits and harms of screening for hepatitis C virus infection (continued … Summary of evidence on comparative benefits and harms of screening for hepatitis C virus infection (continued … (continued) Diagnostic accuracy: FIB-4 vs. liver biopsy Moderate For severe fibrosis (defined as METAVIR … Summary of evidence on comparative benefits and harms of screening for hepatitis C virus infection (continued … (continued) Vertical transmission: Prolonged rupture of membranes vs. less prolonged rupture of membranes
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
    March 01, 2013 - Future Research Recommendations (continued) Research Gaps Future Research Recommendations General Issues … (continued) • Modeling studies to estimate the benefits and harms of different kidney stone evaluation … Future Research Recommendations (continued) Research Gaps Future Research Recommendations Key Question … Future Research Recommendations (continued) Research Gaps Future Research Recommendations Key Question … Future Research Recommendations (continued) Research Gaps Future Research Recommendations Key Question
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - Characteristics of person-time (after baseline), by medication use (continued) Characteristic … Characteristics of person-time (after baseline), by medication use (continued) Characteristic … Characteristics of person-time (after baseline), by medication use (continued) Characteristic … Rate ratios of MI/SCD—standard adjustment (all variables, including those in the CRS) (continued) … Rate ratios of MI/SCD—standard adjustment (all variables, including those in the CRS) (continued)
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
    January 01, 2011 - Incidence of diabetic foot ulcer and lower extremity amputation among Medicare beneficiaries, 2006 to 2008 Diabetic Foot Ulcers Data Points #2 In Medicare Parts A and B fee-for- service beneficiaries with diabetes, the incidence of diabetic foot ulcer is about 6.0% and lower extremity amputation about 0.5%. Am…
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-executive-summary.pdf
    March 01, 2024 - Continued on page 2 2 Background and Purpose ADHD is the single most prevalent
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - Summary of inclusion and exclusion criteria (continued) Study Characteristic Inclusion Criteria Exclusion … Strength of evidence domains for the effect of OC use on ovarian cancer (continued) Comparison Number … Strength of evidence domains for the effect of OC use on ovarian cancer (continued) Comparison Number … Strength of evidence domains for the effect of OC use on breast cancer (continued) Comparison Number … Strength of evidence domains for the effect of OC use on stroke (continued) Comparison Number of Studies
  8. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
    July 01, 2010 - interventions for RC tears Strength Comparison (number of studies) of evidence Summary Operative techniques (continued … Strength Comparison (number of studies) of evidence Summary Nonoperative vs. operative treatment (continued
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/postpartum-care-protocol-appendix%20A.pdf
    December 09, 2021 - Appendix A: Literature Search Page 1 of 4 Appendix A: Literature Search Medline (via PubMed) (((((postpartum OR post-partum OR postnatal OR post-natal OR puerperal OR puerperium OR postdelivery OR post-delivery OR "post delivery" OR "Peripartum Period"[Mesh] OR "fourth trimester" OR "4th trimester") AND ("P…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2023-update-executive-summ.pdf
    January 01, 2023 - Continued on page 2 2 Background and Purpose PTSD is a disorder that results
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
    October 01, 2020 - (continued on page 2) 2 Background and Purpose Colonic diverticulitis is caused by
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rural-telehealth-disposition-comments.pdf
    December 26, 2022 - the studies, the themes of the challenges in implementation, as well as if the interventions were continued
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
    October 05, 2018 - initiation and start of drug holiday, duration of drug holiday, post-drug holiday agent/class ContinuedContinued osteoporosis drug treatment after >1 yr prior osteoporosis drug treatment See Table … illustrates how long-term osteoporosis drug treatment versus control and osteoporosis drug holiday versus continued … Comparisons • For treatment efficacy and harms: Placebo, active contemporaneous control • For drug holiday: Continued
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - Summary of strength of evidence for major outcomes—KQ 1 (PCOS) (continued) 10 Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS) (continued) 11 Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS) (continued) 12 Comparison Outcome … Summary of strength of evidence for major outcomes—KQ 1 (PCOS) (continued) Key Question 2. … Summary of strength of evidence for major outcomes—KQ 3 (unexplained infertility)(continued) 16
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-executive-summary.pdf
    August 01, 2024 - Continued on page 2 2 Background and Purpose CRT with 5FU plus MMC
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
    January 01, 2011 - Economic burden of diabetic foot ulcers and amputations Data Points #3Diabetic Foot Ulcers Beneficiaries with a diabetic foot ulcer are seen by their outpatient health care provider about 14 times per year and are hospitalized about 1.5 times per year. The cost of care for these beneficiaries is substantial, at…
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-269-respectful-maternity-care-summary.pdf
    January 01, 2024 - (Continued on page 2) 2 Background and Purpose Severe maternal morbidity
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
    October 01, 2010 - of key points and recommendations for quantitative synthesis in Comparative Effectiveness Reviews (continued … of key points and recommendations for quantitative synthesis in Comparative Effectiveness Reviews (continued
  20. effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
    October 01, 2010 - of key points and recommendations for quantitative synthesis in Comparative Effectiveness Reviews (continued … of key points and recommendations for quantitative synthesis in Comparative Effectiveness Reviews (continued

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: